Literature DB >> 20213316

Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2/M phase accumulation.

Markus Plate1, Ting Li, Yu Wang, Xiaoning Mo, Yingmei Zhang, Dalong Ma, Wenling Han.   

Abstract

Human CMTM is a novel gene family consisting of CKLF and CMTM1-8. CMTM4 is the most conserved gene and has three RNA splicing forms designated as CMTM4-v1, -v2 and -v3, but in many types of tissue and cell lines, only CMTM4-v1 and -v2 could be detected. CMTM4-v2 is the full length cDNA product, which has been highly conserved during evolution. CMTM4-v1 and -v2 are broadly expressed in normal types of tissue. They are distributed on the cell membrane and across the cytoplasm in a speckled pattern. Overexpression of CMTM4-v1 and -v2 can inhibit HeLa cell growth via G2/M phase accumulation without inducing apoptosis. Therefore, CMTM4 might be an important gene involved in cell growth and cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213316     DOI: 10.1007/s10059-010-0038-7

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  21 in total

1.  Abnormal synaptic vesicle biogenesis in Drosophila synaptogyrin mutants.

Authors:  Robin J Stevens; Yulia Akbergenova; Ramon A Jorquera; J Troy Littleton
Journal:  J Neurosci       Date:  2012-12-12       Impact factor: 6.167

2.  CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.

Authors:  Y Xiao; Y Yuan; Y Zhang; J Li; Z Liu; X Zhang; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

3.  Integrated Analyses of Phenotype and Quantitative Proteome of CMTM4 Deficient Mice Reveal Its Association with Male Fertility.

Authors:  FuJun Liu; XueXia Liu; Xin Liu; Ting Li; Peng Zhu; ZhengYang Liu; Hui Xue; WenJuan Wang; XiuLan Yang; Juan Liu; WenLing Han
Journal:  Mol Cell Proteomics       Date:  2019-03-13       Impact factor: 5.911

4.  Alterations in genetic pathways following radiotherapy for head and neck cancer.

Authors:  Arash O Naghavi; Youngchul Kim; George Q Yang; Kamran A Ahmed; Jimmy J Caudell
Journal:  Head Neck       Date:  2019-12-13       Impact factor: 3.147

5.  CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.

Authors:  Ting Li; Yingying Cheng; Pingzhang Wang; Wenyan Wang; Fengzhan Hu; Xiaoning Mo; Hongxia Lv; Tao Xu; Wenling Han
Journal:  J Exp Clin Cancer Res       Date:  2015-10-16

6.  Large Scale Gene Expression Meta-Analysis Reveals Tissue-Specific, Sex-Biased Gene Expression in Humans.

Authors:  Benjamin T Mayne; Tina Bianco-Miotto; Sam Buckberry; James Breen; Vicki Clifton; Cheryl Shoubridge; Claire T Roberts
Journal:  Front Genet       Date:  2016-10-13       Impact factor: 4.599

7.  Detecting splicing variants in idiopathic pulmonary fibrosis from non-differentially expressed genes.

Authors:  Nan Deng; Cecilia G Sanchez; Joseph A Lasky; Dongxiao Zhu
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

8.  CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.

Authors:  Yu Su; Yi Lin; Lianhai Zhang; Baocai Liu; Wanqiong Yuan; Xiaoning Mo; Xiaohong Wang; Henan Li; Xiaofang Xing; Xiaojing Cheng; Bin Dong; Ying Hu; Hong Du; Yubing Zhu; Ning Ding; Jiyou Li; Weili Liu; Yongzhen Ma; Xiaoyan Qiu; Jiafu Ji; Wenling Han
Journal:  Cancer Sci       Date:  2013-11-28       Impact factor: 6.716

9.  MicroRNA-205 inhibits renal cells apoptosis via targeting CMTM4.

Authors:  Hongxia Zhang; Xiaoning Zhang; Xiaoying Yuan; Linna Wang; Ying Xiao
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

10.  Identification of 526 conserved metazoan genetic innovations exposes a new role for cofactor E-like in neuronal microtubule homeostasis.

Authors:  Melissa Y Frédéric; Victor F Lundin; Matthew D Whiteside; Juan G Cueva; Domena K Tu; S Y Catherine Kang; Hansmeet Singh; David L Baillie; Harald Hutter; Miriam B Goodman; Fiona S L Brinkman; Michel R Leroux
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.